Immunotherapy

New Lung Cancer Treatment Approved

Posted on: November 13, 2015

Today, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Tagrisso, an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC). The FDA also approved the first companion diagnostic test (cobas EGFR Mutation Test v2) to detect the type of EGFR resistance mutation that Tagrisso (osimertinib) is known to target. Tagrisso… read more

Immunotherapy for Lung Cancer Patients

Posted on: November 2, 2015

For patients with advanced or metastatic lung cancer, the treatment options have traditionally been chemotherapy.  First line treatment usually included a platinum containing chemotherapy.  If cancer progressed after that, then the effectiveness of additional chemotherapy was limited.  Now with immunotherapy, we have new and improved treatment options. The goal of immunotherapy is to stimulate the… read more

Shine a Light

Posted on: October 16, 2015

  Join us to Shine a Light on Thursday, November 19 6:30-8:30 PM   Walnut Creek Library – Oak Room 1644 N. Broadway, Walnut Creek, CA 94596 You are invited to an educational event focusing on the unique issues of lung cancer patients.  Join an engaging panel of medical experts as they cover the most… read more

Immunotherapy Giving Hope for Cancer Patients

Posted on: July 1, 2015

There have been exciting advances in the area of immunotherapy for the treatment of cancer in 2015.  Our immune system has the ability to differentiate self versus non-self.  It also plays an important role in controlling cancer. This year’s American Society of Clinical Oncology meeting highlighted some new immunotherapy treatments for a number of cancers… read more